(479) 552-5346
|
info@paramedbilling.com
|
Northgate Drive, Sherwood, AR 72120, USA
(479) 552-5346
ParaMed Billing Solutions - Navigation
Make Payment
Infectious Disease Billing | ParaMed Billing Solutions Free Consultation
Specialty RCM

Infectious Disease
Billing That
Captures Every Code.

ID billing demands mastery of drug administration codes, HIV management, antimicrobial stewardship, and complex multi-system diagnoses. We're the only billing team built specifically for infectious disease physicians — with 97.2% first-pass accuracy.

HIPAA Compliant AAPC Certified 48hr Turnaround All EHR Systems
97.2%
First-Pass Claim Rate
+35%
Avg. Revenue Increase
300+
ID Practices Nationwide
<2%
Average Denial Rate
Billing Complexity

ID Billing: The Most Technically
Demanding Specialty in Medicine

Infectious disease billing involves drug administration tiers, HIV-specific confidentiality rules, complex multi-organism diagnosis coding, antimicrobial stewardship consultation billing, and inpatient critical care crossover — each with its own maze of CMS rules.

01

Drug Administration Code Complexity

ID physicians administer some of the most expensive infusions in medicine — IV antibiotics, antifungals, antivirals, and immunoglobulins. Each requires correct J-code selection, administration code (96365–96379) sequencing, and medical necessity documentation.

Correct hierarchy: initial, sequential, concurrent infusion billing
J-code accuracy for Daptomycin, Ceftaroline, Micafungin
Home infusion vs. office-based site-of-service rules
340B drug discount program compliance
$450K
Avg. annual drug code revenue at risk per ID physician
02

HIV Billing & Confidentiality Rules

HIV/AIDS claims involve state-specific confidentiality regulations, 42 CFR Part 2 protections, and separate payer credentialing requirements. Billing errors here don't just cost money — they risk patient privacy violations and compliance penalties.

42 CFR
Federal privacy rules most billers don't know
03

Why Generic Billers Fail ID Practices

Most billing companies have never heard of a J-code infusion hierarchy, don't know the difference between AMS consultation and a standard consult, and cannot navigate HIV confidentiality billing rules — resulting in systematic underbilling and compliance exposure.

22–30%
Revenue lost by ID practices using generic billers
04

Inpatient Consultation & AMS Billing

ID physicians are among the most consulted specialists in hospital medicine. Billing inpatient consults post-2010 CMS policy change (99241–99245 eliminated for Medicare), correctly applying subsequent visit codes (99231–99233), and billing Antimicrobial Stewardship consultation services requires specialized knowledge that directly impacts hospital-based revenue.

Post-2010 inpatient consult billing using correct subsequent care codes
Critical care (99291/99292) threshold documentation when applicable
05

ICD-10 Multi-Organism Specificity

ID diagnoses require organism-level ICD-10 specificity. Billing sepsis without the causative organism, or using an unspecified code when a specific organism has been identified, triggers automatic medical necessity denials from most payers.

#1
Denial cause: unspecified ICD-10 codes
Revenue Leaks

How ID Practices Lose Revenue
Without Knowing It

Infectious disease has the highest concentration of complex, high-value billing codes in all of outpatient medicine. Each one is a revenue opportunity — and each one is an area where under-trained billers make costly, systematic errors.

Fix My Revenue Leaks
$450K+
Average annual drug code revenue at risk per ID physician
22–30%
Revenue lost annually by practices using generic billers
$200K+
Average AR recovery in first 90 days when switching to ParaMed
01
~$450K/yr at risk

Wrong Infusion Code Hierarchy

Drug administration codes 96365–96379 must follow a strict initial → sequential → concurrent hierarchy. Most billers apply these incorrectly, billing all infusions as "initial" when only one can hold that status per encounter — triggering systematic underpayment and NCCI edit violations.

Revenue Impact: High
02
Compliance risk

HIV Claim Confidentiality Violations

HIV/AIDS billing requires state-specific consent tracking and compliance with 42 CFR Part 2. Sending HIV diagnosis codes on standard EOBs without proper handling can violate patient confidentiality protections and expose your practice to regulatory penalties.

Compliance Risk: Critical
03
~$80–$180 lost per consult

Inpatient Consult Downcoding

Since CMS eliminated consultation codes for Medicare in 2010, ID physicians must bill inpatient consults using hospital care codes (99221–99223 initial, 99231–99233 subsequent). Billers who don't know this bill at the wrong level — losing $80–$180 per hospital consult.

Revenue Impact: High
04
~$62–$130/patient/month missed

CCM & Transitional Care Codes Missed

HIV/AIDS patients and immunocompromised patients qualify for Chronic Care Management codes 99490/99487. ID practices managing large HIV panels are leaving thousands monthly unclaimed. TCM codes (99495/99496) after hospital discharge are also widely ignored.

Revenue Impact: Very High
05
Entire claims denied

Unspecified ICD-10 for Organism-Level Diagnoses

Payers increasingly require organism-specific ICD-10 codes for ID diagnoses. Billing "sepsis, unspecified" (A41.9) when blood cultures identified MRSA (A41.02) or Klebsiella (A41.53) triggers medical necessity denials. Our coders cross-reference lab reports on every claim.

Denial Risk: Critical
06
Unbilled entirely

Antimicrobial Stewardship Consultation Not Billed

Many ID physicians provide formal AMS consultation services to hospitals — yet never bill for them because their billing team doesn't know these services are separately reimbursable. This represents a significant missed revenue stream, especially for physicians with formal AMS program appointments.

Revenue Impact: Medium–High
What We Do

Complete ID Revenue Cycle
Management — All Under One Roof

From drug administration coding to HIV panel management and hospital consult billing — we handle every component of your ID practice's revenue cycle with specialty-specific expertise that generalist billing companies simply cannot match.

ID billing involves 150+ specialty-specific CPT and J-codes, 42 CFR confidentiality compliance, and drug administration hierarchies that require dedicated training. Our team trains specifically for infectious disease.
Start Free Audit
Core Service
HIV/AIDS Revenue Cycle Management

Complete HIV billing management including Ryan White billing, ADAP coordination, payer-specific HIV plan requirements, and 42 CFR Part 2 compliant claim submission and EOB handling.

Ryan White program billing and reporting
HIV-specific payer credentialing
Confidential EOB handling per state law
High Value
Drug Administration & Infusion Billing

Expert J-code selection and administration code hierarchy (96365–96379) for all IV antibiotics, antifungals, antivirals, and immunoglobulins administered in office or outpatient settings.

J-code accuracy for 200+ ID drugs
Initial → sequential → concurrent sequencing
340B compliance for qualifying practices
Hospital Billing
Inpatient Consult & Hospital Care Billing

Post-2010 CMS-compliant inpatient billing for ID consults using correct initial hospital care and subsequent visit codes, with critical care threshold analysis and AMS consultation capture.

99221–99223 initial hospital care coding
Critical care 99291/99292 threshold review
AMS consultation code capture
Ready to stop leaving ID revenue on the table?

Our free revenue audit typically finds $80,000–$300,000 in recoverable revenue for infectious disease practices. No commitment, results in 48 hours.

Defense & Recovery
Denial Management & Appeals

Every denied claim is analyzed within 24 hours and appealed with ID-specific clinical documentation. Our database of payer-specific ID denial patterns means we win 94% of appealed claims.

24-hour denial triage and root cause categorization
Drug code appeal letters with pharmacist documentation support
Medical necessity appeals with clinical literature reference
Systemic denial pattern reporting and prevention
Analytics
Practice Analytics & Revenue Reporting

Real-time dashboard access 24/7 with monthly reports covering net collections, drug administration code utilization, AR aging by payer, denial rate trends, and infusion revenue by drug class.

Live AR aging dashboard with 30/60/90/120+ day buckets
Drug administration revenue by code and drug class
Payer contract performance vs. benchmark analysis
Quarterly strategic review call with your account manager
Code Reference

The Codes That Define Your
ID Practice Revenue

Browse the exact CPT, J-codes, and HCPCS codes our team handles every day for infectious disease practices. If you recognize these, you understand why general billing companies can't serve you well.

96365
IV Infusion — Initial

Initial intravenous infusion up to 1 hour for therapeutic, prophylactic, or diagnostic purposes

~$110–$148
96366
IV Infusion — Add-on Hour

Each additional hour of infusion beyond the initial hour (add-on to 96365)

~$28–$36/hr
96367
IV Infusion — Sequential

Sequential infusion (new drug/substance) up to 1 hour — requires separate drug and separate line

~$34–$42
96368
IV Infusion — Concurrent

Concurrent infusion (add-on) — infused simultaneously with primary infusion

~$21–$28
J0285
Amphotericin B

Injection, amphotericin B, 50mg — high-value antifungal J-code

Drug-specific
J0133
Acyclovir IV

Injection, acyclovir, 5mg — IV antiviral for HSV, VZV

Per mg
J0690
Cefazolin Sodium

Injection, cefazolin sodium, 500mg — commonly used IV cephalosporin

Per 500mg
J3490
Unclassified Drug

Drugs not otherwise classified — requires special documentation and prior authorization tracking

Varies
Z21
HIV Asymptomatic

Asymptomatic HIV infection status — requires 42 CFR compliant EOB handling

HIV-specific
B20
HIV Disease

Human immunodeficiency virus disease — AIDS diagnosis with highest privacy compliance requirements

HIV-specific
99490
Chronic Care Management

CCM for HIV patients with 2+ chronic conditions — 20+ min/month non-face-to-face care

~$62/mo
J0702
Cabotegravir ER

HIV PrEP injection — Apretude/Vocabria. High-value J-code with prior auth requirements

High value
J0740
Cidofovir

Injection, cidofovir, 375mg — used for CMV retinitis in HIV patients

Per dose
G0476
HIV Screening

HIV test, nucleic acid, blood, qualitative — preventive screening with specific payer billing rules

Preventive
99495
TCM — Moderate

Transitional care management — moderate MDM within 14 days of hospital discharge

~$165
99496
TCM — High

Transitional care management — high MDM within 7 days of hospital discharge

~$230
99213
Office Visit — Low

Established patient, low MDM — frequently undercoded in ID outpatient follow-up visits

~$94
99214
Office Visit — Moderate

Established patient, moderate MDM — appropriate level for most ID chronic management visits

~$145
99215
Office Visit — High

Established patient, high MDM — applicable in complex HIV, sepsis follow-up, or immunocompromised patients

~$207
99221
Initial Hospital — Low

Initial hospital care code replacing consult codes post-2010 CMS policy

~$122
99223
Initial Hospital — High

High MDM initial hospital care — applicable for complex ID consults on critically ill patients

~$289
99291
Critical Care — 30–74 min

Critical care time-based billing — when ID physician provides direct critical care management

~$305
99232
Subsequent Hospital — Moderate

Daily subsequent hospital care, moderate MDM — most common code for ongoing ID inpatient consult

~$115
99233
Subsequent Hospital — High

Daily subsequent hospital care, high MDM — for complex ID patients with significant complications

~$167
A41.02
Sepsis — MRSA

Sepsis due to methicillin-resistant Staphylococcus aureus — organism-specific coding required

High complexity
A41.53
Sepsis — Klebsiella

Sepsis due to Gram-negative infection — requires specific lab confirmation for compliant coding

High complexity
B37.1
Pulmonary Candidiasis

Candidal bronchitis/pneumonia — specific fungal organism coding for correct J-code antifungal selection

Drug-linked
A15.0
Pulmonary TB

Tuberculosis of lung, confirmed by sputum microscopy — mandatory organism specificity

Public health
J12.82
Pneumonia — COVID-19

Pneumonia due to coronavirus disease 2019 — active with specific documentation requirements

Active
A49.02
MRSA Infection

Methicillin-resistant Staph aureus infection, unspecified site — triggers specific antibiotic billing

Drug-linked
B00.9
Herpes Simplex

Herpesviral infection — must use specific subtype codes to avoid medical necessity denials

Specificity req.
Z16.11
Resistance to Penicillin

Required secondary code for medical necessity of alternative antibiotic drug administration

Secondary code
How It Works

From First Call to Optimized
Revenue — 4 Steps

We've designed our onboarding specifically for busy ID practices. Full integration in 14 days. No billing gaps. No clinical disruption. Guaranteed.

01
Free Audit

Free Revenue Audit & Gap Analysis

We analyze 3–6 months of your existing claims data to identify every revenue gap — undercoded E/M visits, missed drug administration codes, unappealed denials, and unbilled CCM. You receive a detailed report with a projected annual recovery figure before you sign anything.

E/M level distribution analysis vs national ID benchmarks
Drug administration code accuracy review
Denial rate and root cause breakdown
Projected annual revenue recovery estimate
02
Onboarding

EHR Integration & HIPAA-Compliant Onboarding

We integrate with your existing EHR in 3–5 business days — Epic, athenahealth, eClinicalWorks, NextGen, or any other system. No migrations, no new software. For HIV practices, we implement 42 CFR Part 2 compliant claim handling protocols from day one.

All major EHR systems — 3–5 day integration
42 CFR Part 2 HIV confidentiality protocols activated
BAA signed before any data is accessed
Zero billing gap during transition period
03
Coding & Submission

ID-Specific Coding, Submission & Payment Posting

Every claim is coded by an AAPC-certified coder with ID specialty training — reviewing documentation for E/M level accuracy, drug administration hierarchy, ICD-10 organism specificity, and compliance. Claims submitted within 48 hours, ERA posting follows immediately.

48-hour coding and submission from encounter receipt
Drug hierarchy review for every infusion encounter
ICD-10 organism-level specificity cross-reference
ERA posting and underpayment flagging within 24hrs
04
Optimization

Continuous Optimization & Monthly Reporting

Monthly performance reports with actionable analytics. Denial patterns are analyzed and eliminated. CCM-eligible patients are identified monthly. E/M benchmarks are tracked. Payer contract rates are monitored for underpayment. Your practice keeps improving — month over month, year over year.

Monthly performance report with drug revenue by code
CCM eligibility scan for your patient panel each month
Denial trend analysis and prevention recommendations
Quarterly strategic optimization call
Free ID Billing Audit

Stop Losing ID Revenue to
Billers Who Don't Understand
Your Specialty

Get a free, no-obligation revenue cycle audit. We'll show you exactly what your ID practice is losing and exactly how we'll recover it — before you sign a single contract.

Drug administration code hierarchy review for your infusion encounters
E/M level distribution vs. national ID benchmarks
HIV/CCM eligibility assessment for your patient panel
Denial rate and root cause analysis
Projected annual revenue recovery estimate — in writing
100% free, no obligation, no sales pressure
Request Your Free Billing Audit
No obligation — our ID billing specialists will assess your situation and recommend the fastest path to recovered revenue.

HIPAA compliant · 42 CFR Part 2 protected · No obligation